Posted by Michael Wonder on 13 Nov 2021
CMS repeals MCIT/R&N rule; will consider other coverage pathways to enhance access to innovative medical devices
12 November 2021 - Today, CMS is rescinding the Medicare Coverage of Innovative Technology and Definition of “Reasonable and Necessary” (MCIT/R&N) final rule because of concerns that the provisions in the final rule may not have been sufficient to protect Medicare patients.
By rescinding this rule, CMS can take action that will better address those safety concerns in the future.
